BridgeBio Pharma Inc (BBIO)
25.61
+0.13
(+0.51%)
USD |
NASDAQ |
Nov 04, 13:06
BridgeBio Pharma Profit Margin (Quarterly): -3.39K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -3.39K% |
| March 31, 2024 | -16.68% |
| December 31, 2023 | -9.64K% |
| September 30, 2023 | -4.33K% |
| June 30, 2023 | -9.62K% |
| March 31, 2023 | -7.68K% |
| December 31, 2022 | -7.36K% |
| September 30, 2022 | -40.63K% |
| June 30, 2022 | -13.36% |
| March 31, 2022 | -11.59K% |
| Date | Value |
|---|---|
| December 31, 2021 | -1.14K% |
| September 30, 2021 | -6.65K% |
| June 30, 2021 | -178.3% |
| March 31, 2021 | -35.30K% |
| December 31, 2020 | -98.35K% |
| September 30, 2020 | -1.43K% |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -531.6% |
| September 30, 2019 | -224.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-98.35K%
Minimum
Dec 2020
-13.36%
Maximum
Jun 2022
-13.99K%
Average
-6.65K%
Median
Sep 2021
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | -22.27% |
| Pfizer Inc | 25.22% |
| Vertex Pharmaceuticals Inc | -135.8% |
| PTC Therapeutics Inc | -53.12% |
| Bristol-Myers Squibb Co | 10.18% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -67.76% |
| Return on Invested Capital | -87.43% |
| Gross Profit Margin (Quarterly) | 72.42% |
| Operating Margin (Quarterly) | -7.96K% |
| Return on Net Operating Assets | -468.5% |